Navigation Links
Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
Date:2/4/2009

GAITHERSBURG, Md. and ATLANTA, Feb 4 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, and Expression Therapeutics, a biotechnology company specializing in factor VIII-based therapeutics, today announced a collaborative agreement to co-develop novel cell and protein therapies for Hemophilia A.

Hemophilia A is an inherited blood clotting disorder caused by a mutation in the factor VIII gene resulting in a deficiency of factor VIII protein. Lentigen and Expression Therapeutics will develop two types of treatments for Hemophilia: a novel chimeric factor VIII protein for direct injection and a cell therapy that may permanently correct the disorder.

"Hemophilia A is a serious disease, affecting about one in 10,000 people worldwide," explained Dr. Boro Dropulic, President and Chief Scientific Officer of Lentigen. "The two therapeutic approaches leverage Lentigen's technology in two important areas: protein expression and cell therapy. Factor VIII is a difficult protein to manufacture but Lentigen's protein expression technology will permit the production of a novel human factor VIII protein at levels highly favorable for commercialization. Secondly, Expression Therapeutics' proprietary factor VIII will be used in a novel stem cell therapy for Hemophilia A that aims to restore the clotting capability of patients suffering from this debilitating disease.

"The platform technology developed by Expression Therapeutics will be used to advance the treatment of hemophilia A. By combining our high expression factor VIII technology with Lentigen's protein expression and gene transfer capabilities, we are confident Lentigen is the ideal partner to help bring this technology to the clinic and marketplace," stated Dr. Trent Spencer, President of Expression Therapeutics.

Tim Ravenscroft, Lentigen's Chief Executi
'/>"/>

SOURCE Lentigen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza
2. Lentigen Corporation Announces Relocation to New Facility
3. Lentigen Appoints Jim Meade as Vice President of Corporate Development
4. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
5. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
6. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
7. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
8. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
9. VIRxSYS and Lentigen Announce Litigation Settlement
10. New technique allows simultaneous tracking of gene expression and movement
11. Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)... The Vanuatu National Adv...its Second National Communication (SNC) Project in...vices and CLIMsystems Ltd. of New Zealand have gen...se results that will form the background for the c... Framework Convention on Climate Change (UNFCCC). ...
(Date:11/27/2009)..., , PARIS, November 27 /PRNewswire-Fir...approval to market Oralair(R) in both adults and c...rmany, the first country where,Oralair(R) has been... Oralair(R) is now registered in Austria, Belgi... France, Germany, Greece, Hungary, Ireland, Italy,...
(Date:11/26/2009)..., , WEST LAFAYETTE, Ind. - A new generation of u...hips using tiny structures called semiconducting n...ry by researchers at IBM, Purdue University and th... researchers have learned how to create nanowires ...y defined at the atomic level, which is a critical...
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...e H1N1 virus, genomic data from the 1918 pandemic ...the current H1N1 pandemic, today issued its latest...hows that the lethality of the H1N1 ("Swine Flu") ...during the virus,s current outbreak in the spring ...
Breaking Biology Technology:Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5
... of Group Purchasing Organizations Hosted,by Trane...ociety of,Healthcare Engineering (ASHE) offers pro...- and this years, annual conference is no exceptio..., a leading global supplier of,indoor comfort syst...s from Trane will make two presentations at the 45...
...set, Inc.,(Nasdaq: VRUS ) announced today that it... 14, 2008 with a select group of institutional,inv...k in a "registered,direct" offering. The investors...price of $17.85 per share resulting in gross proce...before deducting placement agent,fees and estimate...
...PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC ...ny"), a leading Chinese firm specializing in the m...stribution of probiotics products,today announced ... Company,("AST") as its new transfer agent and reg...red in New York, New York, replaces the Company,s ...
Other Biology Technology:Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 3Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock 2Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock 3China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008 2
(Date:11/24/2009)...ave crystallised a protein that may help gut bacte...n could be used by probiotic producers to identify...people. , "Probiotics need to interact with cells...f they attach to surfaces in the gut they are more... activity," says Dr Nathalie Juge from the Institu...
(Date:11/24/2009)...evel action of a remarkable class of ring-shaped p...th the Lawrence Berkeley National Laboratory (Berk...lography beamline at the Advanced Light Source (AL...e expression and replication, and are vital to the...ctious agents, such as the human papillomavirus, w...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife C... revealing that the last remaining population of S...ue to the rising tide of poaching and habitat loss...form Russian officials of what needs to be done to...est cat. , The report was released ...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Carbon nanoparticles toxic to adult fruit flies but benign to young 9513 1Carbon nanoparticles toxic to adult fruit flies but benign to young 9513 2Carbon nanoparticles toxic to adult fruit flies but benign to young 9513 3Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11 2009 53945 1Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 1Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 2
...rup and his colleagues from the University of Cope...pebjerg Hospital have followed a soccer team consi... For a period of 3 months, the players have been s...ngs, total mass of muscles, percentage of fat, blo...Surprising results ,- 2-3 weekly rounds of soccer ...
...Chicago have discovered a chemical compound in mal... first time in any species that an entire enzyme s...ex. , The research, performed using nuclear magn...oS ONE, the peer-reviewed, open-access resource fr...one level differences are generally accepted as th...
... World War II, actinide,chemistry has been essenti...sts still seek the ability to interpret and predic...pounds and materials using first principle theory....oal closer to achievement. , PNNL scientist Jun L...utational actinide chemistry at the national meeti...
Other Biology News:Soccer burns more fat than jogging 2Soccer burns more fat than jogging 3First finding of a metabolite in 1 sex only 2
...prehensive array of accessories. JULABO water bat...ater protected keypad offer a high operating comfo...o 6 temperature values is visible from across the ...emperature control eliminates temperature overshoo...
Poly-HRP Dilution Buffer from Endogen
... an aqueous solution that contains a purified bovi...ls in a MOPS buffer (3-(N-Morpholino) propanesulfo...ombination of 0.02% methylisothiazolone, 0.02% bro...as Company) as a preservative. StabilZyme HRP Con...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Biology Products: